Professor of Neuropharmacology, University of Central Lancashire
Colin Davidson is a neuropharmacologist and neurochemist. His main research interest is in drug abuse, and he has studied many of the new psychoactive substances or ‘legal highs’. He is particularly interested in their pharmacology and their effects on transmitter release. Previously, while an Assistant Professor in Psychiatry at Duke University, he tested novel pharmacotherapies for stimulant abuse. He has also published in the field of Stroke where he has an interest in pre-ischaemic conditioning. His PhD was in the field of antidepressants and 5-HT efflux.
Colin was Head of School in the School of Pharmacy & Biomedical Sciences at the University of Central Lancashire (2017-23). Previously Colin held faculty positions at St George’s University of London, University of Leicester and Duke University Medical Centre. Colin has a BSc in Biology & Psychology from the University of Edinburgh, a PhD from Queen Mary’s, University of London and was a postdoc at the University of St Andrews.
The synthetic opioid fentanyl is well known for the many lives it has claimed – mainly in the US, but elsewhere too. Now, a less well-known class of synthetic opioids called nitazenes is starting to crop up in overdose cases, on both sides of the Atlantic.
The synthetic opioid fentanyl is well known for the many lives it has claimed – mainly in the US, but elsewhere too. Now, a less well-known class of synthetic opioids called nitazenes is starting to crop up in overdose cases, on both sides of the Atlantic.
This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.
Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide
Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community.
Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.
Clinical Articles
